论文部分内容阅读
目的研究并探讨采用尼莫地平治疗蛛网膜下腔出血患者的临床效果。方法研究选取我院在2009年3月-2011年9月收治的120例蛛网膜下腔出血患者,所有患者都自愿接受调查和服从所有准则,将这些患者作为研究对象,并随机分为观察组和对照组。在对照组中,对患者给予常规性治疗,在观察组中,除给予常规性治疗外,还给予尼莫地平进行治疗,观察两组患者在死亡率和致残率两方面指标,并将所得到的资料进行对比分析研究。结果在死亡率和致残率方面,观察组明显低于对照组,二者之间有着本质上差异,差异具有统计学意义。结论研究表明,对蛛网膜下腔出血患者进行尼莫地平治疗,能够有效降低患者的死亡率和致残率,因此该方法值得在临床上推广和使用。
Objective To study and discuss the clinical effect of nimodipine in the treatment of patients with subarachnoid hemorrhage. METHODS: A total of 120 patients with subarachnoid hemorrhage admitted to our hospital from March 2009 to September 2011 were selected. All patients were volunteered for investigation and obeyed all criteria. All patients were randomly divided into observation group And control group. In the control group, the patients were given routine treatment. In the observation group, nimodipine was given to the observation group as well as routine treatment. The mortality and morbidity rate of the two groups were observed, The data obtained for comparative analysis. Results In terms of mortality and morbidity, the observation group was significantly lower than that of the control group, there was an essential difference between the two, the difference was statistically significant. Conclusion The study shows that nimodipine for patients with subarachnoid hemorrhage can effectively reduce the mortality and morbidity of patients with subarachnoid hemorrhage, so the method is worthy of clinical promotion and use.